Allogeneic γ9δ2 T Cells therapy Anhui Provincial Hospital)

N/A

Report date: 2023/03/07 20:00:45

Base Information

Drug NameAllogeneic γ9δ2 T Cells therapy Anhui Provincial Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsHematologic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAnhui Provincial Hospital
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Provincial Hospital
Inactive CompaniesN/A
Active IndicationsHematologic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A